Imexpharm

Imexpharm Acquisitions (Net)

The Acquisitions (Net) of Imexpharm (IMP.VN) as of Oct 26, 2026 is -49.70 B VND. In the previous year, Acquisitions (Net) was -30.43 B VND — a change of 63.35% (lower).

Acquisitions (Net)

-49.70 BVND

YoY

63.35%

Last updated:

Acquisitions (Net) of Imexpharm is 2025 -49.70 B VND. Acquisitions (Net) of Imexpharm was 2024 -30.43 B VND. It decreases by 63.35% lower compared to the previous year.

The Imexpharm Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
224.34 B VND
Jan 1, 2019
10.50 B VND
Jan 1, 2020
-46.79 B VND
Jan 1, 2021
-30.29 B VND
Jan 1, 2022
-99.95 B VND
Jan 1, 2023
142.65 B VND
Jan 1, 2024
-30.43 B VND
Jan 1, 2025
-49.70 B VND
The Imexpharm Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-49.70 BVND+63.35%
-30.43 BVND-121.33%
142.65 BVND-242.72%
-99.95 BVND+230.03%
-30.29 BVND-35.28%
-46.79 BVND-545.55%
10.50 BVND-95.32%
224.34 BVND-232.91%
-168.79 BVND-288.46%
89.56 BVND-196.19%
-93.11 BVND+1,794.23%
-4.92 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Acquisitions (Net) of Imexpharm is -49.70 B VND in 2025.

Acquisitions (Net) of Imexpharm changed from -30.43 B VND to -49.70 B VND, representing a 63.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Imexpharm

All Key Metrics — Imexpharm